To evaluate the safety and performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Freedom from all-cause mortality
Timeframe: 30 days
Freedom from major adverse events
Timeframe: 30 Days
Reduction of Mitral Regurgitation to optimal or acceptable
Timeframe: 30 days